Bucindolol v placebo for advanced chronic heart failure (CHF)†
| Outcomes at mean 2 years | Bucindolol | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| †Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| All-cause mortality | 30% | 33% | 8% (−2 to 18) | Not significant |
| Mortality from cardiovascular diseases | 25% | 29% | 12% (0.4 to 22) | 29 (15 to 790) |
| Hospitalisation for CHF | 35% | 42% | 16% (8 to 24) | 15 (10 to 32) |